Dr Felicia Teo is a respiratory physician and intensivist at Mount Elizabeth Hospital, Singapore.
She has special interests in interstitial lung disease, airway diseases, endobronchial ultrasound, pulmonary infections in the immunocompromised, as well as intensive care.
She was a senior consultant in the department of medicine at the National University Hospital (NUH). She is currently a visiting consultant for the interstitial lung disease (ILD) clinic at NUH.
Dr Teo received her specialty training in Singapore, and is dual-accredited in respiratory medicine and intensive care medicine. She trained at the interstitial lung diseases unit at the Royal Brompton Hospital, London.
In 2015, Dr Teo initiated and led the ILD service at NUH. She collaborated with rheumatology colleagues to provide one-stop rheumatology-ILD service to patients with connective-tissue disease ILD. She was also the first-line designated referral consultant for respiratory immuno-oncology service in NUH to meet the needs of haemato-oncology patients with immune-checkpoint inhibitor toxicities.
In 2022, she was involved in the setup of the national interstitial lung disease service registry on the NUH site, in collaboration with Singapore General Hospital and Tan Tock Seng Hospital.
Besides her clinical work, she was an assistant professor in the department of medicine at Yong Loo Lin School of Medicine, National University of Singapore. She is also a core faculty member for the National PGY1 programme at the National University Health System.
She has served as an advisory board member and consultant for Boehringer Ingelheim and AstraZeneca in use of antifibrotic and oncology drugs.
Dr Teo is a recipient of several awards including the Long Service Award, Service Quality Partner’s Award, and the Severe Acute Respiratory Syndrome Courage Award.
-2002 MRCP (UK) (RCP, United Kingdom)
-2020 FRCP (RCP, London, United Kingdom)